EE219 Cost-Effectiveness of Dapagliflozin Vs. Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction

Abstract

Authors

A. Rane R.N. Nechi M. Imam C.R. Zoni C. Ndikumukiza I. Karaye I. Yunusa A. Alanazi

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×